Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2017 | The analysis of neurotoxicity at ASH 2017

David Maloney • 10 Dec 2017
ASH 2017

David Maloney, BSc, MD, PhD, of Fred Hutchinson Cancer Research Center, Seattle, WA, discusses one of his highlights at ASH 2017 – the analysis of neurotoxicity. He explains that neurotoxicity is related to high levels of cytokines and endothelial breakdown, allowing the diffusion of cytokines into the brain. This can result in severe toxicity. New strategies are therefore currently being worked on to prevent this toxicity.
Recorded at American Society of Hematology 2017 Annual Meeting, held in Atlanta, GA.

More from David Maloney

Expanding the CAR platform in NHL
David Maloney et al. • 17 Oct 2023
14:23
Highlights from Day 2: addressing challenges in CAR-T therapy for ALL, AML, CLL & more…
David Maloney et al. • 30 Apr 2022
10:21
Advances in CAR-T therapy for lymphoma
Caron Jacobson et al. • 1 May 2022
4:36
Highlights from the immunotherapy in CLL session
David Maloney • 20 Sep 2021
The content of VJHemOnc is intended for healthcare professionals